Chase Investment Counsel Corp Raises Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Chase Investment Counsel Corp grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 25.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,420 shares of the company’s stock after acquiring an additional 1,497 shares during the quarter. Chase Investment Counsel Corp’s holdings in HealthEquity were worth $711,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in HQY. Louisiana State Employees Retirement System increased its stake in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after acquiring an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund increased its stake in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after acquiring an additional 100 shares during the last quarter. Raymond James Trust N.A. increased its stake in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after acquiring an additional 132 shares during the last quarter. CIBC Asset Management Inc increased its stake in HealthEquity by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 2,640 shares of the company’s stock worth $253,000 after acquiring an additional 139 shares during the last quarter. Finally, Sanctuary Advisors LLC increased its stake in HealthEquity by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock worth $320,000 after acquiring an additional 159 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Trading Up 2.6 %

Shares of HQY opened at $109.76 on Friday. The company has a market capitalization of $9.51 billion, a P/E ratio of 100.70, a P/E/G ratio of 1.60 and a beta of 0.55. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a 50-day moving average price of $104.84 and a 200 day moving average price of $93.08.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 earnings per share. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on HQY. Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Finally, Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $113.54.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,000 shares of company stock valued at $3,895,788. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.